In this issue:
Sickle cell disease: A growing global challenge
First-line venetoclax combinations in CLL
Fixed duration ibrutinib plus venetoclax for patients with high-risk features
Base-edited CAR-T cells for relapsed T-cell ALL
CPX-351 in higher risk MDS and CMML
Relapsed/refractory lymphoma occurring during pregnancy
Predicting risk of myeloid malignancy in clonal haematopoiesis
New ASH guideline on thrombophilia testing
Screening and diagnosing significant haemoglobinopathies
Interfant-21 study recruitment begins mid-2023
COVID-19 resources
Conferences, workshops and CPD
Please login below to download this issue (PDF)